Skip to main content

Security report for ultomirispregnancystudy.com

IQVIA · Healthcare · United States

Low risk. 2 critical or high findings in GDPR outside view and SSL/TLS.

Security score

78/100

Risk levelLow

0–100, higher is better. How it is calculated

The Ultomiris Pregnancy Registry Study website serves as a clinical research platform focused on enrolling and informing pregnant or breastfeeding women who have been prescribed ULTOMIRIS for autoimmune conditions. The site is professionally designed and targets both patients and healthcare providers in the United States. It provides detailed information about the study, medication, and participation methods, supported by links to official prescribing information and medication guides. The parent company IQVIA is prominently referenced, lending credibility to the site. Technically, the website employs a modern technology stack including jQuery, Bootstrap, Vue.js, and Google Tag Manager, with Sitecore CMS inferred from cookie names. The site is mobile-optimized and includes accessibility features, though some improvements could be made. Security measures include HTTPS enforcement, Google reCAPTCHA integration, and a comprehensive cookie consent mechanism. However, explicit security headers are not detected, and no incident response or security policy pages are present. From a security and compliance perspective, the site demonstrates good privacy compliance with clear privacy and cookie policies and user consent mechanisms. The absence of WHOIS data for the domain is a notable anomaly, reducing trust slightly, but the professional content and association with IQVIA mitigate concerns. No vulnerabilities or exposed sensitive data were detected. Overall, the website is a credible and professionally maintained clinical research registry with moderate to good technical and security posture. Strategic improvements in security headers, incident response transparency, and domain registration clarity would enhance trust and compliance.

Scanned

NIS2 and GDPR posture

GDPR outside view
68/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

2 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching ultomirispregnancystudy.com

This scan found 18 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
67
Security headers
85
Email security
70
DNS health
75
Network security
100
GDPR outside view
68
Average
78

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The website operates within the healthcare sector, specifically focusing on clinical research for a niche patient population using the drug ULTOMIRIS. Its business model revolves around patient registry enrollment and data collection to support post-marketing surveillance and safety studies. The site targets US residents and healthcare professionals, leveraging partnerships with Alexion (manufacturer) and IQVIA (parent company and research services provider). The presence of official medication guides and prescribing information links strengthens its market positioning. The site’s content and design reflect a medium to large enterprise level of professionalism, consistent branding, and trust signals. The lack of direct company emails and incomplete WHOIS data suggest areas for operational transparency improvement.

Security posture

The website exhibits a good security posture with HTTPS enforced and integration of Google reCAPTCHA to prevent spam. Cookie management is robust, offering users granular control over cookie preferences and compliance with GDPR-like standards. However, the absence of explicit security headers such as Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options is a gap that should be addressed to mitigate common web vulnerabilities. No incident response or security policy pages are found, limiting transparency on how security incidents are handled. The WHOIS data absence is a concern for domain legitimacy verification. Overall, the site is secure but could improve in header implementation and incident response visibility.

Recommendations

  1. Implement and verify security headers including Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options to enhance protection against common attacks.
  2. Publish a clear security policy and incident response plan accessible to users and partners to improve transparency and trust.
  3. Investigate and resolve the WHOIS data absence to ensure domain registration transparency and legitimacy.
  4. Add verified company contact emails to improve communication channels and business credibility.
  5. Regularly audit third-party scripts and dependencies to ensure no vulnerable libraries are in use.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
IQVIA
Description
A clinical research study website for the Ultomiris Pregnancy Registry Study targeting pregnant women or those previously pregnant who have taken ULTOMIRIS for autoimmune diseases.
Key services
Patient enrollment for pregnancy registry, Healthcare provider login and patient referral, Information dissemination about ULTOMIRIS and pregnancy
Content quality
good
Branding
consistent

Technology

Stack
jQuery, Bootstrap, Google Tag Manager, Google reCAPTCHA, FontAwesome, Vue.js, Handlebars.js, Moment.js, DataTables
Frameworks
Bootstrap
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Use of Google reCAPTCHA for spam protection
  • Cookie consent management with opt-in/out
  • Session management cookies

Analytics and tracking

Services
Google Analytics, Sitecore Analytics
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Google reCAPTCHA
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is a specialized clinical research registry for Ultomiris pregnancy study.
  2. Content is professionally presented and targeted to US residents and healthcare providers.
  3. Comprehensive cookie and privacy policies with user consent mechanisms are implemented.
  4. No direct company contact emails found; contact is via phone and forms.
  5. No security.txt or explicit incident response info found.
  6. WHOIS data unavailable, which is a concern but mitigated by professional site content and known parent company IQVIA.
Technical notes

Notes

The website is built on a modern and widely supported technology stack including jQuery, Bootstrap, Vue.js, and Handlebars.js, with Sitecore CMS inferred from cookie names and analytics cookies. It uses Google Tag Manager and Google Analytics for tracking and performance monitoring, alongside Google reCAPTCHA for spam protection. The site is mobile responsive and includes accessibility features, though some areas could be enhanced. Performance is moderate, with no explicit hosting provider identified. The site uses multiple JavaScript libraries and CSS frameworks to deliver a rich user experience. Technical risks include missing security headers and reliance on multiple third-party scripts which require ongoing monitoring.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with ultomirispregnancystudy.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review ultomirispregnancystudy.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.